Description
| Product Name | CAT.No | Size |
| Thalassaemia (α & ß) Control Level 1 | BXC0665A | 2 x 0.5ml |
| Thalassaemia (α & ß) Control Level 2 | BXC0665B | 2 x 0.5ml |
Product Description
The Biorex Diagnostics Thalassaemia Control provides human serum–based, ready-to-use or lyophilised materials for accurate quality control of thalassaemia assays. These controls ensure precision, reproducibility, and reliability in clinical laboratories, supporting the accurate diagnosis of α- and ß-thalassaemia, carrier detection, and prenatal screening.
Key Features
• Human serum–based – closely mimics patient samples for clinically relevant testing
• Multi-analyte coverage – includes HbA2, HbF, and HbS for comprehensive haemoglobin variant monitoring
• Precision and accuracy assessment – monitors assay reproducibility across runs and instruments
• Flexible formats – available in liquid stable or lyophilised forms for long-term stability
Benefits
Routine use enables laboratories to maintain high standards in thalassaemia testing, detect assay variations early, and ensure compliance with ISO 15189, CAP, and CLIA standards. These controls support reliable quantification of haemoglobin variants, enhancing diagnostic confidence and strengthening laboratory quality assurance programs.